| |
4 Webinars
Taking Place: April - May 2021
Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer (myelin sheath) surrounding the nerves in both the central nervous system and the peripheral nervous system, ultimately affecting intellectual and motor function. Early-onset clinical manifestations are often overlooked or confused with other conditions causing confusion among the non-trained HCPs of the first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in the start of treatment have significant consequences on the conditions’ development, and the patient’s health and quality of life. This delay in referral and treatment must be overcome. The 4 webinars in the Series will cover the basics of MLD, practical neurological case studies that offer the opportunity to connect the theory with the practice and treatment options.
|
|
